Invention Grant
- Patent Title: Heterobivalent ligands suitable for use in the treatment of Parkinson's disease
-
Application No.: US16606065Application Date: 2018-04-14
-
Publication No.: US11053270B2Publication Date: 2021-07-06
- Inventor: Özge Sensoy , Mustafa Güzel , Bilal Ersen Kerman , Neslihan Üstündag Okur , Samman Mansoor , Essam Hanashalshahaby , Elif Keskin , Serdar Durdagi , Gülru Kayik
- Applicant: T.C ISTANBUL MEDIPOL ÜNIVERSITESI , BAHÇESEHIR ÜNIVERSITESI
- Applicant Address: TR Istanbul; TR Istanbul
- Assignee: T.C ISTANBUL MEDIPOL ÜNIVERSITESI,BAHÇESEHIR ÜNIVERSITESI
- Current Assignee: T.C ISTANBUL MEDIPOL ÜNIVERSITESI,BAHÇESEHIR ÜNIVERSITESI
- Current Assignee Address: TR Istanbul; TR Istanbul
- Priority: TR2017/05700 20170418
- International Application: PCT/TR2018/050166 WO 20180414
- International Announcement: WO2019/004970 WO 20190103
- Main IPC: C07H19/16
- IPC: C07H19/16 ; A61K31/7076 ; A61P25/28 ; A61K45/06
Abstract:
Disclosed are novel drug molecules and use of the novel drug molecules in the treatment of neurodegenerative diseases, such as Parkinson's disease.
Public/Granted literature
- US20210147421A1 HETEROBIVALENT LIGANDS SUITABLE FOR USE IN THE TREATMENT OF PARKINSON'S DISEASE Public/Granted day:2021-05-20
Information query
IPC分类:
